Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
45 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
001548-C
A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination with Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects with Biliary Tract Carcinoma (BTC)
Recruitment has not started
0-120 Years
NCI
Biliary Tract
21-C-0006
Phase II Study Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Participants currently recruited/enrolled
18-125 Years
NCI
Biliary Tract
20-C-0152
Phase II Study of combination of Trametinib (MEK inhibitor) and Hydroxychloroquine (HCQ) (autophagy inhibitor) in Patients with KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
Completed Study; data analyses ongoing
18-125 Years
NCI
Biliary Tract
19-C-0094
A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinoma (BTC)
Participants currently recruited/enrolled
18-125 Years
NCI
Biliary Tract
16-C-0135
A Pilot Study of Combined Immune Checkpoint Inhibition in combination with Ablative Therapies in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
Completed Study; data analyses ongoing
18-125 Years
NCI
Biliary Tract
13-C-0202
Tissue Procurement and Natural History Study of Patients with Malignant Mesothelioma and Other Mesothelin Expressing Cancers
Participants currently recruited/enrolled
2-125 Years
NCI
Biliary Tract
001572-C
A Phase II Study of Bevacizumab in Adults with Recurrent Respiratory Papillomatosis (RRP)
Participants currently recruited/enrolled
18-120 Years
NCI
Tract
001547-C
A First-in-Human Phase I Trial with Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
Recruitment has not started
18-120 Years
NCI
Tract
001535-C
A Phase II Study of Sacituzumab Govitecan with or without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer
Recruitment has not started
18-120 Years
NCI
Tract
001533-C
A Phase II Multicenter Study of Enfortumab Vedotin with or without Pembrolizumab in Rare Genitourinary Tumors
Recruitment has not started
18-120 Years
NCI
Tract
000871-CC
Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults
Participants currently recruited/enrolled
18-60 Years
CC
Tract
000809-I
A Pilot Study of Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
Participants currently recruited/enrolled
10-60 Years
NIAID
Tract
000494-DK
Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Participants currently recruited/enrolled
18-100 Years
NIDDK
Tract
000491-C
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
000417-CC
Characterization of the Nociception Phenotype in Individuals with Intellectual Disability
Participants currently recruited/enrolled
8-30 Years
CC
Tract
000302-C
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
000281-I
Pilot Assessment To Find Evidence of Gastric Motility Abnormalities in Eosinophilic Gastric Disorders
Participants currently recruited/enrolled
18-59 Years
NIAID
Tract
000251-C
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
Participants currently recruited/enrolled
18-120 Years
NCI
Tract
000130-DK
Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach
Participants currently recruited/enrolled
18-125 Years
NIDDK
Tract
21-C-0026
A Phase I/II Study of Abemaciclib in Patients with HIV-associated and HIV-negative Kaposi Sarcoma
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
21-C-0017
Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
21-C-0013
A Phase I/II Study of Adjuvant PRGN-2012 in Adult Patients with Recurrent Respiratory Papillomatosis
Participants currently recruited/enrolled
18-120 Years
NCI
Tract
20-I-0123
A Longitudinal Study of COVID-19 Sequelae and Immunity
Participants currently recruited/enrolled
18-125 Years
NIAID
Tract
20-CH-0126
Data Collection Study of Pediatric and Adolescent Gynecology Conditions
Participants currently recruited/enrolled
0-125 Years
NICHD
Tract
20-C-0061
Phase I/II study of NHS-IL12 Monotherapy and in Combination with M7824 in Advanced Kaposi Sarcoma
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
19-C-0143
A Phase II Study Using the Administration of Autologous T-Cells Engineered using the Sleeping Beauty Transposon/Transposase System to Express T-Cell Receptors Reactive Against Mutated Neoantigens in Patients with Metastatic Cancer
Recruitment has not started
18-70 Years
NCI
Tract
19-C-0138
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination with Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
19-C-0041
Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
18-I-0039
Challenge Infection of Healthy Adult Volunteers with RSV A2
Completed Study; data analyses ongoing
18-50 Years
NIAID
Tract
16-C-0171
Phase I/II Study of Lenalidomide Combined with Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-Associated Large Cell Lymphoma
No longer recruiting/follow-up only
18-125 Years
NCI
Tract
16-C-0047
A Phase 1 Trial of Pomalidomide in Combination with Liposomal Doxorubicin in Patients with Advanced or Refractory Kaposi Sarcoma
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
15-I-0148
A Phase I Study of Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers
Completed Study; data analyses ongoing
18-50 Years
NIAID
Tract
15-C-0087
Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens from Healthy Volunteers and Urothelial Cancer Patients
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
13-I-0062
A Double Blind Randomized Placebo Controlled Study Examining the Effects of a Non-Absorbable (Rifaximin) Antibiotic on the Chronic Immune Activation Observed In HIV-infected Subjects
Completed Study; data analyses ongoing
18-65 Years
NIAID
Tract
11-H-0046
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Completed Study; data analyses ongoing
18-100 Years
NHLBI
Tract
11-E-0006
The Role of TGF-Beta in Asthmatic Epithelial Cell Susceptibility to RSV Infection
Completed Study; data analyses ongoing
18-60 Years
NIEHS
Tract
11-C-0112
Acquisition of Blood and Tumor Tissue Samples from Patients with Gastrointestinal Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
Tract
10-I-0109
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Participants currently recruited/enrolled
18-125 Years
NIAID
Tract
10-C-0166
A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab
Participants currently recruited/enrolled
18-72 Years
NCI
Tract
09-H-0172
Natural History of Bronchiectasis
Participants currently recruited/enrolled
5-100 Years
NHLBI
Tract
09-C-0100
A Pilot Study of High Dose Rate Brachytherapy in The Radiation Oncology Branch
Participants currently recruited/enrolled
18-125 Years
NCI
Biliary
08-DK-0098
Natural History of Familial Carcinoid Tumor
Participants currently recruited/enrolled
18-125 Years
NIDDK
Tract
07-H-0142
Research Respiratory Tract Procedures
Participants currently recruited/enrolled
10-100 Years
NHLBI
Tract
98-CH-0081
Clinical and Basic Investigations into Smith-Lemli-Opitz Syndrome
Completed Study; data analyses ongoing
0-125 Years
NICHD
Tract
82-I-0183
A Natural History Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut
Participants currently recruited/enrolled
0-75 Years
NIAID
Tract